Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0000950170-25-095288
Filing Date
2025-07-11
Accepted
2025-07-11 16:05:10
Documents
14
Period of Report
2025-07-11

Document Format Files

Seq Description Document Type Size
1 6-K/A esmo_gi_-_7-11-25_amende.htm 6-K/A 32880
2 EX-99.1 imab-ex99_1.htm EX-99.1 86523
3 EX-99.2 imab-ex99_2.htm EX-99.2 11431
4 GRAPHIC img44095488_0.jpg GRAPHIC 40503
5 GRAPHIC imab-ex99_2s1.jpg GRAPHIC 339561
6 GRAPHIC imab-ex99_2s2.jpg GRAPHIC 264262
7 GRAPHIC imab-ex99_2s3.jpg GRAPHIC 356589
8 GRAPHIC imab-ex99_2s4.jpg GRAPHIC 395748
9 GRAPHIC imab-ex99_2s5.jpg GRAPHIC 411675
10 GRAPHIC imab-ex99_2s6.jpg GRAPHIC 540702
11 GRAPHIC imab-ex99_2s7.jpg GRAPHIC 327222
12 GRAPHIC imab-ex99_2s8.jpg GRAPHIC 365309
13 GRAPHIC imab-ex99_2s9.jpg GRAPHIC 391062
14 GRAPHIC imab-ex99_2s10.jpg GRAPHIC 215043
  Complete submission text file 0000950170-25-095288.txt   5154184
Mailing Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850
Business Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850 (301) 670 2800
I-Mab (Filer) CIK: 0001778016 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)